[go: up one dir, main page]

CN111819188A - 融合单链DNA聚合酶Bst、编码融合DNA聚合酶NeqSSB-Bst的核酸分子、其制备方法和用途 - Google Patents

融合单链DNA聚合酶Bst、编码融合DNA聚合酶NeqSSB-Bst的核酸分子、其制备方法和用途 Download PDF

Info

Publication number
CN111819188A
CN111819188A CN201980017798.1A CN201980017798A CN111819188A CN 111819188 A CN111819188 A CN 111819188A CN 201980017798 A CN201980017798 A CN 201980017798A CN 111819188 A CN111819188 A CN 111819188A
Authority
CN
China
Prior art keywords
leu
glu
lys
bst
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980017798.1A
Other languages
English (en)
Inventor
玛尔塔·斯皮比达
卡西亚·斯密艾珂
马辛·奥泽维斯基
达维德·尼兹沃斯基
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute Of Biotechnology And Molecular Medicine
Original Assignee
Institute Of Biotechnology And Molecular Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute Of Biotechnology And Molecular Medicine filed Critical Institute Of Biotechnology And Molecular Medicine
Publication of CN111819188A publication Critical patent/CN111819188A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1252DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/24Extraction; Separation; Purification by electrochemical means
    • C07K1/26Electrophoresis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07007DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/80Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/10Nucleotidyl transfering
    • C12Q2521/101DNA polymerase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Electrochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

本发明的主题是融合单链DNA聚合酶Bst及其制备方法,该融合单链DNA聚合酶Bst在该聚合酶的N端使用由氨基酸序列Gly‑Ser‑Gly‑Gly‑Val‑Asp的六个氨基酸组成的接头与NeqSSB蛋白连接,其中给定的聚合酶以三种不同的变体存在。此外,本发明的主题是编码融合DNA聚合酶NeqSSB‑Bst全长、大片段、短片段的核酸分及它们的用途。

Description

融合单链DNA聚合酶Bst、编码融合DNA聚合酶NeqSSB-Bst的核 酸分子、其制备方法和用途
技术领域
本发明的主题是融合单链DNA聚合酶Bst及其制备方法。本发明的主题还是编码根据Bst聚合酶的三种变体:全长、大片段、短片段中的一种的融合聚合酶NeqSSB-Bst的核酸分子,以及融合DNA聚合酶用于等温扩增反应的用途。
背景技术
DNA聚合酶是在DNA复制和修复过程中起重要作用的酶。它们被广泛应用于各个科学领域,并成功用于测序PCR或各种PCR(聚合酶链反应)变体中,在该PCR变体中,它们在体外催化DNA合成过程,并且该反应以精确定义的热阶段进行循环。另一种越来越流行的方法是在DNA扩增的等温技术中利用DNA聚合酶,这些等温技术不基于热循环,并且反应在恒定的延伸温度下进行。迄今为止,已经开发出许多这种用于DNA扩增和RNA扩增的技术。用于给定技术的合适聚合酶的选择主要取决于其性质。除了基本的聚合能力外,由于存在核酸外切结构域或逆转录酶活性,聚合酶还表现出水解DNA分子的能力。这些特征由各个结构域的存在来确定。这些酶中存在的基本结构域是聚合结构域和3'-5'和5'-3'核酸外切结构域。存在如下的聚合酶,在该聚合酶中,核酸外切结构域的缺失使得获得与天然酶相比具有部分改变的特征的功能蛋白。这种类型中最流行的聚合酶是从水生栖热细菌中分离出的Taq聚合酶,该Taq聚合酶的发现完全改变了分子生物学。不具有5'-3'核酸外切酶活性,
Figure BDA0002670769580000011
聚合酶显示出更高的热稳定性,同时它需要更多的Mg2+离子,并且新形成的DNA链包含的错误更少。Bst聚合酶用于等温扩增技术。它的天然形式包含非活性3'-5'核酸外切结构域和活性5'-3'核酸外切结构域,这些活性可以因在73位(Tyr73→Phe73和Tyr73→Ala73)中的点突变而丧失。该聚合酶以及Taq聚合酶是A家族的一部分,并且从细菌嗜热脂肪芽孢杆菌中分离出。它的最佳活性约为60℃,并且没有核酸外切酶活性,该聚合酶表现出链置换活性,该链置换活性在环介导的等温扩增(LAMP)反应中非常有用。与该家族中的其他聚合酶相比,该聚合酶对临床或环境抑制剂的耐受性有所提高,但考虑到该聚合酶的应用,寻找能够主要能使得其进行性和抗抑制剂性提高的解决方案是重要的。
NeqSSB蛋白是单链DNA结合(Single-Stranded Binding,SSB)蛋白家族的成员。SSB蛋白具有多种氨基酸序列和结构。然而,它们仍然包含一个由约100个氨基酸组成的特征性高度保守的寡核苷酸/寡糖结合(OB)折叠结构域。该结构域广泛存在于表现出ssDNA结合能力的蛋白质中,并因此决定了所有SSB蛋白质共有的基本特征-对单链DNA的非特异性结合以及后来发现的RNA结合能力。SSB蛋白在与ssDNA紧密相关的过程中起着关键作用。它们在复制、重组和DNA修复中至关重要。这些蛋白质负责与单链DNA的相互作用、防止二级结构的产生并防止被核酸酶降解。
SSB蛋白的发现可追溯到1960年代上半叶。首先被发现的SSB蛋白是T4噬菌体和大肠杆菌的SSB蛋白。在发现过程中,阐明了它们强的与ssDNA相互作用和使用高盐浓度(2MNaCl)的ssDNA-纤维素珠洗脱蛋白的能力。此外,还发现了该蛋白质对单链DNA的非常高的选择性。SSB蛋白在与ssDNA相关的过程中的基本作用被以下事实得到证实:这些蛋白存在于所有活生物体以及病毒中。
SSB蛋白与ssDNA的结合是基于寡核苷酸链残基之间的芳香族氨基酸残基的堆积。而且,带正电荷的氨基酸残基与ssDNA分子的磷酸骨架相互作用。
尽管NeqSSB蛋白属于SSB蛋白家族的事实,但它因其特征而与经典SSB蛋白偏离,因此它被称为NeqSSB样蛋白。该蛋白源自超嗜热古菌Nanoarchaeum equitans,其是craenarchaeon Ignicoccus hospitalis的寄生生物。这种微生物的最佳生长条件需要严格的厌氧条件和90℃的温度。有趣的是,Nanoarchaeum equitans包含最小的已知基因组,其由490885个碱基对组成。与大多数已知的基因组减少的生物体相反,该微生物包含参与复制、修复和DNA重组的全套酶,包括SSB蛋白。
NeqSSB蛋白以及该家族的其他蛋白具有与DNA结合的天然能力。它由243个氨基酸残基组成,并且在其结构中包含一个OB结构域,并且与某些病毒SSB蛋白类似,作为单体具有生物活性。报告显示,与其他SSB蛋白相比,NeqSSB蛋白表现出涉及没有结构偏好地与所有DNA形式(ssDNA、dsDNA)和mRNA结合的不同寻常的能力。而且,该蛋白质表现出高的热稳定性。在能保持生物活性的同时,半衰期在100℃下为5分钟,而变性温度(meltingtemperature)为100.2℃。
为了满足现代诊断、分子生物学或基因工程提出的要求,需要改进DNA聚合酶以在这些科学领域中提供有用的功能。迄今为止引入的修饰主要集中在引入改良的缓冲液、扩增反应增强剂或DNA聚合酶的突变。突变使得获得热稳定性和对临床或环境样品中存在的抑制剂的抗性增加的酶。
DNA聚合酶的作用机制包括几个重要步骤。第一步由酶与DNA基质的连接组成。由于3'OH端对核苷酸磷原子的亲核进攻而使所获得的DNA-DNA复合物将相应的dNTPs(脱氧核糖核苷酸三磷酸)缔合。最后一步导致磷酸二酯键的产生和焦磷酸的释放。
这些酶的聚合作用的负责其最终效率的重要阶段之一是与基质DNA结合有关的初始过程。由于这个原因,对已知聚合酶进行修饰是合理的,以便于结合到进行聚合的DNA链。这种修饰的示例可以是产生与表现出能与单链和/或双链DNA结合的天然能力的蛋白融合的融合DNA聚合酶。文献仅呈现了这种融合DNA聚合酶的几个示例,其中大多数示例是与主要用于聚合酶链反应的热稳定酶的融合。
研究表明,Taq、Pfu、Tpa或KOD DNA聚合酶与超嗜热古菌Sulfolobussolfataricus的DNA结合蛋白Sso7d的融合可使聚合酶的进行性增加5倍至17倍。类似地,在与其结合单链DNA的天然SSB蛋白(RB69SSB)融合后,观察到RB69噬菌体的DNA聚合酶的进行性(processivity)和忠实性增加。
欧洲专利EP 1 934 372B1公开了热球菌zilligi的与古菌Sulfolobussolfataricus的SsoSSB蛋白融合的DNA聚合酶,其表明了修饰后的酶的效率和进行性增加。
此外,最近报道了TaqStoffel聚合酶与能够结合所有类型的DNA的NeqSSB蛋白以及P.furiosus连接酶的DBD结构域的融合。两种融合均使得酶功能特性得到提高,特别是提高了天然酶的进行性和热稳定性,并显著增加了其对临床抑制剂(乳铁蛋白、肝素、全血)的耐受性。还进行了等温反应中使用的聚合酶(诸如Bst和
Figure BDA0002670769580000021
)的少量融合。这些聚合酶通过Methanopyrus kandleri的拓扑异构酶V的HhH(螺旋-发夹-螺旋)结构域连接,这增加了聚合酶与DNA的亲和力,而对链置换活性没有负面影响(在融合聚合酶Bst和
Figure BDA0002670769580000022
中)。而且,观察到使用质粒和基因组DNA的更高的忠实性和扩增效率(在为
Figure BDA0002670769580000023
的情况下)。
文献还呈现了从地芽孢杆菌(Geobacillus sp.)777中分离出的Bst样聚合酶的融合。产生了聚合酶与连接酶Pyrococcus abyssi的DBD结构域和Sto7d蛋白的嵌合体,并且与天然聚合酶相比,该嵌合体表现出在进行性和对抑制剂(尿素、全血、肝素、EDTA、NaCl和乙醇)的抗性方面的增强。
发明内容
本发明的目的是提供一种与结合所有类型的DNA和RNA的NeqSSB蛋白融合的融合DNA聚合酶Bst。出人意料的是,本发明在很大程度上解决了该问题。
本发明的主题是一种与结合所有类型的DNA和RNA的NeqSSB蛋白融合的融合DNA聚合酶Bst。对以下三种Bst聚合酶变体进行了修饰:全长-由于点突变而丧失5'-3'活性的DNA|Bst聚合酶的整个氨基酸序列;大片段-无5'-3'结构域的DNA|Bst聚合酶;以及短片段-两个核酸外切结构域都缺失的短版本。使用包含六个氨基酸的接头,通过聚合酶N端将Bst聚合酶的所有变体与NeqSSB蛋白融合。
本发明的本质是单链DNA聚合酶Bst或这类DNA聚合酶的另一种聚合酶的融合聚合酶,该单链DNA聚合酶Bst或这类DNA聚合酶的另一种聚合酶与NeqSSB蛋白或与序列在不高于50%的程度上与NeqSSB相似的蛋白在聚合酶的N端使用示例性氨基酸序列Gly-Ser-Gly-Gly-Val-Asp的接头连接或在不使用接头的情况下直接融合,其中所述聚合酶以三种不同的变体存在。
融合DNA聚合酶NeqSSB-Bst,其包含以下三种Bst聚合酶变体中的一种:
-全长-由于点突变而使5'-3'活性丧失的DNA聚合酶|Bst的整个氨基酸序列;
-大片段-无5'-3'结构域的DNA聚合酶|Bst;
-短片段-两个外切核酸结构域都缺失的短版本。
融合DNA聚合酶NeqSSB-Bst,其与所有类型的DNA和RNA结合。
具有SEQ1中所示的序列的融合DNA聚合酶NeqSSB-Bst。
具有SEQ2中所示的序列的融合DNA聚合酶NeqSSB-Bst。
具有SEQ3中所示的序列的融合DNA聚合酶NeqSSB-Bst。
SEQ4中所示的编码融合DNA聚合酶NeqSSB-Bst全长的核酸分子。
SEQ5中所示的编码融合DNA聚合酶NeqSSB-Bst大片段的核酸分子。
SEQ6中所示的编码融合DNA聚合酶NeqSSB-Bst短片段的核酸分子。
上面限定的编码融合DNA聚合酶NeqSSB-Bst的核酸分子。
上面限定的融合DNA聚合酶NeqSSB-Bst的制备方法,在该制备方法中:
-第一步包括在优化的条件下,在微生物振荡器中表达编码该酶的基因:生长温度28℃至37℃,诱导后培养基的温育时间-3h至20h,诱导剂浓度-0.1mM至1mM IPTG,
-使用超声对所获得的细胞裂解物进行分解,并使用dsDNase消除DNA基因组污染。
-第二纯化步骤利用使用His-Trap珠的金属亲和色谱,
-下一步骤包括对制剂的三重透析(10mM Tris-HCl,pH 7.1,50mM KCl,1mM DTT,0.1mM EDTA,50%甘油,0.1%Triton X-100)、凝胶过滤和浓缩。
-所有过程均在4℃下进行,
-使用SDS-PAGE电泳测试所获得的蛋白的纯度,并使用EvaEZ荧光聚合酶活性测定试剂盒确定所获得的制剂的单位数量。
上面限定的融合单链DNA聚合酶Bst在体外用于等温扩增反应的用途。
序列和附图说明
序列1-示出了融合聚合酶NeqSSB-Bst全长的氨基酸序列,
序列2-示出了融合聚合酶NeqSSB-Bst大片段的氨基酸序列,
序列3-示出了融合聚合酶NeqSSB-Bst短片段的氨基酸序列,
序列4-示出了编码融合DNA聚合酶NeqSSB-Bst全长的基因的序列,
序列5-示出了编码融合DNA聚合酶NeqSSB-Bst大片段的基因的序列,
序列6-示出了编码融合DNA聚合酶NeqSSB-Bst短片段的基因的序列,
图1-示出了在融合DNA聚合酶纯化的各个阶段中蛋白质的10%聚丙烯酰胺凝胶电泳分离,
M-蛋白质量标记物(Thermo-Fischer Scientific),其具有标准蛋白的质量:116kDa;66.2kDa;45kDa;35kDa;25kDa;18.4kDa;14.4kDa;
1-重组大肠杆菌TOP10F′-pETNeqSSB-Bst菌株的整个无细胞提取物;
2-经过初步热变性的整个无细胞提取物;
3-未与His-Trap色谱柱结合的部分;
4-含有40mM咪唑的His-Trap珠的洗涤部分;
5-含有100mM咪唑的His-Trap珠的洗涤部分;
6-在使用500mM咪唑洗脱后收集的含有融合DNA聚合酶的部分;
图2-示出了关于EvaGreen染料荧光与从融合DNA聚合酶的DNA扩增开始的时间的依赖关系的图表,其使得能够计算DNA聚合酶的单位数量。图例将反应中使用的DNA聚合酶的量以微升分配成曲线。
图3-示出了在各种表达条件下的裂解物的10%聚丙烯酰胺凝胶电泳分离,
M-蛋白质量标记物(Thermo-Fischer Scientific),其具有标准蛋白的质量:116kDa;66.2kDa;45kDa;35kDa;25kDa;18.4kDa;14.4kDa;
1-重组大肠杆菌TOP10F′-pETNeqSSB-Bst菌株在诱导前的整个无细胞提取物;
2-用1mM IPTG诱导后3小时的整个无细胞提取物,在28℃下进行表达;
3-用1mM IPTG诱导后4小时的整个无细胞提取物,在28℃下进行表达
4-用1mM IPTG诱导后5小时的整个无细胞提取物,在28℃下进行表达
5-用1mM IPTG诱导后6小时的整个无细胞提取物,在28℃下进行表达
6-用1mM IPTG诱导后20小时的整个无细胞提取物,在28℃下进行表达
7-用0.1mM IPTG诱导后3小时的整个无细胞提取物,在28℃进行表达;
8-用0.1mM IPTG诱导后4小时的整个无细胞提取物,在28℃下进行表达
9-用0.1mM IPTG诱导后5小时的整个无细胞提取物,在28℃下进行表达
10-用0.1mM IPTG诱导后6小时的整个无细胞提取物,在28℃下进行表达
11-用0.1mM IPTG诱导后20小时的整个无细胞提取物,在28℃下进行表达
12-重组大肠杆菌TOP10F′-pETNeqSSB-Bst菌株在诱导前的整个无细胞提取物;
13-用1mM IPTG诱导后3小时的整个无细胞提取物,在37℃下进行表达;
14-用1mM IPTG诱导后4小时的整个无细胞提取物,在37℃下进行表达
15-用1mM IPTG诱导后5小时的整个无细胞提取物,在37℃下进行表达
16-用1mM IPTG诱导后6小时的整个无细胞提取物,在37℃下进行表达
17-用1mM IPTG诱导后20小时的整个无细胞提取物,在37℃下进行表达
18-重组大肠杆菌TOP10F′-pETNeqSSB-Bst菌株在诱导前的整个无细胞提取物;
19-用0.1mM IPTG诱导后3小时的整个无细胞提取物,在37℃下进行表达;
20-用0.1mM IPTG诱导后4小时的整个无细胞提取物,在37℃下进行表达
21-用0.1mM IPTG诱导后5小时的整个无细胞提取物,在37℃下进行表达
22-用0.1mM IPTG诱导后6小时的整个无细胞提取物,在37℃下进行表达
23-用0.1mM IPTG诱导后20小时的整个无细胞提取物,在37℃下进行表达
图4-示出了表示与参考DNA聚合酶|Bst相比,融合DNA聚合酶的活性随温度升高而变化的曲线图。蓝线表示DNA聚合酶|Bst的结果,红线表示融合DNA聚合酶Bst全长,紫线表示融合DNA聚合酶Bst大片段,并且绿线表示融合DNA聚合酶Bst短片段。使用GelAnalyzer程序基于琼脂糖凝胶中获得的PCR产物的强度对活性进行描述。
图5-示出了在具有溴化乙锭的1.5%琼脂糖凝胶中的电泳分离,其表示对DNA聚合酶的进行性的比较,该进行性被定义为等温PCR期间的扩增速率。反应在各列指示的不同时间段内进行。
图6-示出了在1.5%琼脂糖凝胶中的电泳分离,其表示对DNA聚合酶对以下抑制剂的抗性的比较:血液乳铁蛋白(A)、土壤多酚(B)。
A:
A:1-在添加6μg乳铁蛋白的情况下,由DNA扩增产生的反应产物
2-在添加0.6μg乳铁蛋白的情况下,由DNA扩增产生的反应产物
3-在添加0.06μg乳铁蛋白的情况下,由DNA扩增产生的反应产物
4-在添加6ng乳铁蛋白的情况下,由DNA扩增产生的反应产物
K+在不添加抑制剂的情况下,在DNA扩增期间产生的反应产物。
B:
1-在添加100μg多酚的情况下,由DNA扩增产生的反应产物
2-在添加10μg多酚的情况下,由DNA扩增产生的反应产物
3-在添加1μg多酚的情况下,由DNA扩增产生的反应产物
4-在添加0.1μg多酚的情况下,由DNA扩增产生的反应产物,
5-在添加0.01μg多酚的情况下,由DNA扩增产生的反应产物,
K+在不添加抑制剂的情况下,在DNA扩增期间产生的反应产物。
图7-示出了在具有溴化乙锭的2%琼脂糖凝胶中的电泳分离,其表示在融合DNA聚合酶存在下,DNA电泳迁移率变动分析的结果。反应混合物包含10pmol(dT76)的荧光素标记(绿色)和2.5pmol PCR产物的100bp(橙色)
1-d(T)76
2-100bp
3-d(T)76+100bp+3.3pmol融合DNA聚合酶
4-d(T)76+100bp+6.6pmol融合DNA聚合酶
5-d(T)76+100bp+13.2pmol融合DNA聚合酶
6-d(T)76+100bp+26.4pmol融合DNA聚合酶
7-d(T)76+100bp+52.8pmol融合DNA聚合酶
8-d(T)76+100bp+105.6pmol融合DNA聚合酶
9-d(T)76+100bp+211.2pmol融合DNA聚合酶
通过实施方式来说明本发明,该实施方式包括但不限于此。
具体实施方式
实施例:
融合DNA聚合酶NeqSSB-Bst
融合DNA聚合酶NeqSSB-Bst通过使用接头使三种不同的Bst聚合酶在聚合酶N-端与NeqSSB蛋白融合而获得,该接头由的六个氨基酸组成,序列为:Gly-Ser-Gly-Gly-Val-Asp。融合DNA聚合酶的三种变体的序列在附图SEQ.1-3(氨基酸序列)和SEQ.4-6(核苷酸序列)中给出。DNA聚合酶在基于大肠杆菌的原核系统中以实验室规模获得。
制备-实施例1
DNA聚合酶制备的第一步包括在以下优化的条件下,在微生物振荡器中表达编码酶的基因:生长温度-30℃,诱导后培养基的温育时间-3h至20h,诱导剂浓度-0.1mM至1mMIPTG。在蛋白质纯化过程中,使用超声波将所获得的细胞裂解物进行分解,并使用dsDNase除去DNA基因组污染。由于寡聚组氨酸结构域的存在,第二纯化步骤利用了使用His-Trap珠的金属亲和色谱法(图1)。接下来的步骤包括制剂的三重透析,直到获得可为DNA聚合酶提供稳定性的条件(10mM Tris-HCl pH 7.1,50mM KCl,1mM DTT,0.1mM EDTA,50%甘油,0.1%Triton X-100)、凝胶过滤和增浓。所有过程均在4℃下进行。使用SDS-PAGE电泳测试所获得的蛋白的纯度,并使用Biotium(USA)的EvaEZ荧光聚合酶活性测定试剂盒根据以下的单位定义来确定所获得的制剂的单位数量:1个活性单位[1U]为在其最佳操作温度65℃下,可在30分钟内结合10nmol核苷酸的DNA聚合酶的量(图2)。1升实验室规模的培养物可提供约5mg纯化的制剂,其活性约为10 000U,该活性能实现相应数量的扩增反应。
制备-实施例2
编码融合DNA聚合酶的基因的表达在28℃的温度下,在能为液体培养物提供适当的充氧的条件下进行。使用IPTG诱导对数期培养物,IPTG具有能提供蛋白表达的量-IPTG在1mM至0.1mM的范围内,并温育3小时至20小时(图3)。之后,使用金属亲和色谱和离子交换色谱将细胞裂解物机械进行分解并纯化。对所获得的融合DNA聚合酶进行透析以获得其储存条件(10mM Tris-HCl pH 7.1,50mM KCl,1mM DTT,0.1mM EDTA,50%甘油,0.1%Triton X-100),并且基于Biotium(USA)的商业EvaEZ荧光聚合酶活性测定试剂盒,根据单位的定义以1U/μL的浓度提供。
制备-实施例3
在37℃的培养和1mM至0.1mM范围内的IPTG诱导3小时至20小时下,获得了编码与NeqSSB蛋白融合的聚合酶Bst的基因的有效表达(图3)。使用色谱技术(金属亲和色谱和离子交换色谱)对离心和机械破碎后的细胞裂解物进行纯化,将其悬浮于配制缓冲液(10mMTris-HCl pH 7.1,50mM KCl,1mM DTT,0.1mM EDTA,50%甘油,0.1%Triton X-100)中,并以1U/μL的浓度提供。使用Biotium(USA)的EvaEZ荧光聚合酶活性测定试剂盒,基于单位的定义了DNA单位的数量。
本发明主题的酶的性质与参考DNA聚合酶Bst的比较分析已经表明,另外的结合DNA的NeqSSB蛋白的存在对DNA聚合酶的性质具有积极影响。与参考DNA聚合酶Bst相比,所有获得的DNA聚合酶融合变体的热稳定性均增加了约20%。(图4)。而且,与NeqSSB蛋白融合的DNA聚合酶显示出进行性增加了三倍(图5)。与参考聚合酶相比,融合DNA聚合酶耐受反应混合物中的临床抑制剂(乳铁蛋白、肝素)和环境抑制剂(腐殖酸、土壤、多酚)的浓度增加了甚至数十倍(图6)。与参考DNA聚合酶Bst相比,融合DNA聚合酶表现出灵敏度增加了几倍,并因此表现出对DNA基质的亲和力增加。
参考文献
[1]Patel P.H.,Motoshi S.,Adman E.,Shinkai A,Prokaryotic DNAPolymerase I:Evolution,Structure and Base Flipping Mechanism for NucleotideSelection,J Mol Biol.,2001,308:823-837.
[2]Steitz T.A.,The Journal of Biological Chemistry,1999,274:17395-17398
[3]Riggs M.G.,Tudor S.,Siva ram M.,McDonough S.H.Construction ofsingle amino acid substitution mutants of cloned BacillusstearothermophilusDNA polymerase I which lack 5'→3'exonucleaseactivity.Biochim Biophys Acta,1996;1307(2):178-86.
[4]Oscorbin,I.P.,Belousova E.A.,Boyarskikh U.A.,Zakabunin A.I.,Khrapov E.A.,Filipenko M.L.,Derivatives of Bst-like Gss-polymerase withimproved processivity and inhibitor tolerance,Nucleic Acids Research,2017,45(16):9595-9610
[5]Phang S.M.,Teo C.Y.,Lo E.,Wong V.W.Cloning and complete sequenceof the DNA polymerase-encoding gene(BstpolI)and characterisation of theKienow-like fragment from Bacillus stearothermophilus.Gene.1995;163(1):65-8.
[6]Nowak M,Olszewski M,
Figure BDA0002670769580000061
M,Kur J.Characterization of single-stranded DNA-binding proteins from the psychrophilic bacteria Desulfotaleapsychrophila,Flavobacterium psychrophilum,Psychrobacter arcticus,Psychrobacter cryohalolentis,Psychromonas ingrahamii,Psychroflexus torquis,and Photobacterium profundum.BMC Microbiol.2014;14:91.
[7]Kur J,Olszewski M,Dtugolecka A,Filipkowski P.Single-stranded DNA-binding proteins(SSBs)-sources and applications in molecular biology.ActaBiochim Pol.2005;52(3):569-74.
[8]Sigal N,Delius H,Kornberg T,Gefter ML,Alberts B.A DNA-unwindingprotein isolated from Escherichia coli:its interaction with DNA and with DNApolymerases.Proc Natl Acad Sci U S A.1972;69(12):3537-41.
[9]Olszewski M,Balsewicz J,Nowak M,Maciejewska N,Cyranka-Czaja A,
Figure BDA0002670769580000072
B,
Figure BDA0002670769580000073
R,Kur J.Characterization of a Single-Stranded DNA-Binding-Like Protein from Nanoarchaeum equitans-A Nucleic Acid Binding Protein withBroad Substrate Specificity.PloS One.2015;10(5):e0126563
[10]Kim K.P.,Cho S.S.,Lee K.K.,Youn M.H.,Kwon S.T.Improvedthermostability and PCR efficiency of Thermococcuscelericrescens DNApolymerase via site-directed mutagenesis,J Biotechnol.,2011,10;155(2):156-63
[11]Kermekchiev M.B.,Kirilova LI.,Vail E.E.,Barnes W.M.,Mutants ofTaq DNA polymerase resistant to PCR inhibitors allow DNA amplification fromwhole blood and crude soil samples,Nucleic Acids Res,2009,37(5):e40
[12]Patel PH,Suzuki M,Adman E,Shinkai A,Loeb LA.Prokaryotic DNApolymerase I:evolution,structure,and"base flipping"mechanism for nucleotideselection.J Mal Biol.2001;308(5):823-37
[13]Wang Y.,Prosen D.E.,Mei L.,Sullivan J.C.,Finney M.,Vander HomP.B.,A novel strategy to engineer DNA polymerases for enhanced processivityand improved performance In vitro,2004Nucleic Acid Research,32(3)
[14]Lee J.I.,Cho S.S.,Eui-JoonKil E.J.,Kwon S.T.,Characterization andPCR application of a thermostable DNA polymerase from Thermococcuspacificu,Enzyme and Microbial Technology 47(2010)147-152
[15]Wang F,Li S,Zhao H,Bian L,Chen L,Zhang Z,Zhong X,Ma L,YuX.Expression and Characterization of the RKOD DNA Polymerase in Pichiapastoris.PLoS One.2015;10(7):e0131757.
[16]Sun S.,Geng L.,Shamoo Y.,Structure and Enzymatic Properties of aChimeric Bacteriophage RB69 DNA Polymerase and Single-Stranded DNA BindingProtein with Increased processivity,PROTEINS:Structure,Function,andBioinformatics,2006,65:231-238
[17]SSB-POLYMERASE FUSION PROTEINS,European Patent Office,EP1934372Bl,date of filing:08.09.2006,date of publication:20.02.2013
[18]
Figure BDA0002670769580000074
M,Krawczyk B,
Figure BDA0002670769580000075
B,
Figure BDA0002670769580000076
R,Wysocka M,OlszewskiM.Fusion of DNA-binding domain of Pyrococcus furiosus ligase with TaqStoffelDNA polymerase as a useful tool in PCR with difficult targets.Appl MicrobiolBiotechnol.2018;102(2):713-721.
[19]Olszewski M,
Figure BDA0002670769580000077
M,Bilek M,Krawczyk B.Fusion of Taq DNApolymerase with single-stranded DNA binding-like protein of Nanoarchaeumequitans-Expression and characterization.PLoS One.2017;12(9):e0184162
[20]de Vega M.,Lázaro J.M.,Mencia M.,Blanco L.,Salas M.,Improvementof
Figure BDA0002670769580000071
DNA polymerase amplification performance by fusion of DNA bindingmotifs,PANS,2010;107(38):16506-16511
[21]Pavlov A.R.,Pavlova N.V.,Kozyavkin S.A.,Slesarev A.I.,Cooperationbetween Catalytic and DNA-binding Domains Enhances Thermostability andSupports DNA Synthesis at Higher Temperatures by Thermostable DNAPolymerases,Biochemistry.2012;51(10):2032-2043.
[22]Tveit H.,Kristensen T.,Fluorescence-Based DNA PolymeraseAssay.Anal Biochem.2001;289:96-8.
核苷酸和氨基酸序列
SEQ.1.
MDEEELIQLIIEKTGKSREEIEKMVEEKIKAFNNLISRRGALLLVAKKLGVLYKNTPKEKKIGELESWEYVKVKGKILKSFGLISYSKGKFQPIILGDETGTIKAIIWNTDKELPENTVIEAIGKTKINKKTGNLELHIDSYKILESDLEIKPQKQEFVGICIVKYPKKQTQKGTIVSKAILTSLDRELPVVYFNDFDWEIGHIYKVYGKLKKNIKTGKIEFFADKVEEATLKDLKAFKGEADGSGGVDLKNKLVLIDGNSVAYRAFFALPLLHNDKGIHTNAVYGFTMMLNKILAEEQPTHILVAFDAGKTTFRHETFQDAKGGRQQTPPELSEQFPLVRELLKAYRIPAYELDHYEADDIIGTMAARAEREGFAVKVISGDRDLTQLASPQVTVEITKKGITDIESYTPETVVEKYGLTPEQIVDLKGLMGDKSDNIPGVPGIGKKTAVKLLKQFGTVENVLASIDEIKGEKLKENLRQYRDLALLSKQLAAICRDAPVELTLDDIVYKGEDREKVVALFQELGFQSFLDKMAVQTDEGEKPLAGMDFAIADSVTDEMLADKAALVVEVVGDNYHHAPIVGIALANERGRFFLRPETAVADPKFLAWLGDETKKKTMFDSKRAAVALNGKGIELAGVGVVFDLLLAAYLLDPAQAAGDVAAVAKMHQYEAVRSDEAVYGKGAKRTVPDEPTLAEQLVRKAAAIWALEEPLMDELRRNEQDRLLTELEHALAGILANMEFTGVKVDTKRLEQMGAELTEQLQAVERRIYELAGQEFNINSPKQLGTVLFDKLQLPVLKKTKTGYSTSADVLEKLAPHHEIVEHILHYRQLGKLQSTYIEGLLKVVHPVTGKVHTMFNQALTQTGRLSSVEPNLQNIPIRLEEGRKIRQAFVPSEPDWLIFAADYSQIELRVLAHIAEDDNLIEAFRRWLDIHTKTAMDIFHVSEEDVTANMRRQAKAVNFGIVYGISDYGLAQNLNITRKEAAEFIERYFASFPGVKQYMDNIVQEAKQKGYVTTLLHRRRYLPDITSRNFNVRTFAERTAMNTPIQGSAADIIKKAMIDLSVSVREERLQARLLLQGHDELILEAPKEEIGRLCRLVPEVMEQAVTLRVPLKVDYHYGPTWYDAK
长度:1127aa
类型:氨基酸序列
分子类型:蛋白质
SEQ.2.
MDEEELIQLIIEKTGKSREEIEKMVEEKIKAFNNLISRRGALLLVAKKLGVLYKNTPKEKKIGELESWEYVKVKGKILKSFGLISYSKGKFQPIILGDETGTIKAIIWNTDKELPENTVIEAIGKTKINKKTGNLELHIDSYKILESDLEIKPQKQEFVGICIVKYPKKQTQKGTIVSKAILTSLDRELPVVYFNDFDWEIGHIYKVYGKLKKNIKTGKIEFFADKVEEATLKDLKAFKGEADGSGGVDLADKAALVVEVVGDNYHHAPIVGIALANERGRFFLRPETAVADPKFLAWLGDETKKKTMFDSKRAAVALNGKGIELAGVGVVFDLLLAAYLLDPAQAAGDVAAVAKMHQYEAVRSDEAVYGKGAKRTVPDEPTLAEQLVRKAAAIWALEEPLMDELRRNEQDRLLTELEHALAGILANMEFTGVKVDTKRLEQMGAELTEQLQAVERRIYELAGQEFNINSPKQLGTVLFDKLQLPVLKKTKTGYSTSADVLEKLAPHHEIVEHILHYRQLGKLQSTYIEGLLKVVHPVTGKVHTMFNQALTQTGRLSSVEPNLQNIPIRLEEGRKIRQAFVPSEPDWLIFAADYSQIELRVLAHIAEDDNLIEAFRRWLDIHTKTAMDIFHVSEEDVTANMRRQAKAVNFGIVYGISDYGLAQNLNITRKEAAEFIERYFASFPGVKQYMDNIVQEAKQKGYVTTLLHRRRYLPDITSRNFNVRTFAERTAMNTPIQGSAADIIKKAMIDLSVSVREERLQARLLLQGHDELILEAPKEEIGRLCRLVPEVMEQAVTLRVPLKVDYHYGPTWYDAK
长度:816aa
类型:氨基酸序列
分子类型:蛋白质
SEQ.3.
MDEEELIQLIIEKTGKSREEIEKMVEEKIKAFNNLISRRGALLLVAKKLGVLYKNTPKEKKIGELESWEYVKVKGKILKSFGLISYSKGKFQPIILGDETGTIKAIIWNTDKELPENTVIEAIGKTKINKKTGNLELHIDSYKILESDLEIKPQKQEFVGICIVKYPKKQTQKGTIVSKAILTSLDRELPVVYFNDFDWEIGHIYKVYGKLKKNIKTGKIEFFADKVEEATLKDLKAFKGEADGSGGVDLELRRNEQDRLLTELEHALAGILANMEFTGVKVDTKRLEQMGAELTEQLQAVERRIYELAGQEFNINSPKQLGTVLFDKLQLPVLKKTKTGYSTSADVLEKLAPHHEIVEHILHYRQLGKLQSTYIEGLLKVVHPVTGKVHTMFNQALTQTGRLSSVEPNLQNIPIRLEEGRKIRQAFVPSEPDWLIFAADYSQIELRVLAHIAEDDNLIEAFRRWLDIHTKTAMDIFHVSEEDVTANMRRQAKAVNFGIVYGISDYGLAQNLNITRKEAAEFIERYFASFPGVKQYMDNIVQEAKQKGYVTTLLHRRRYLPDITSRNFNVRTFAERTAMNTPIQGSAADIIKKAMIDLSVSVREERLQARLLLQGHDELILEAPKEEIGRLCRLVPEVMEQAVTLRVPLKVDYHYGPTWYDAK
长度:663aa
类型:氨基酸序列
分子类型:蛋白质
SEQ.4.
ATGGATGAAGAGGAACTAATACAACTAATAATAGAAAAAACTGGCAAATCTCGAGAGGAAATAGAAAAAATGGTGGAAGAAAAAATTAAAGCTTTTAACAATTTAATATCTCGTAGGGGGGCTTTACTATTAGTAGCAAAAAAACTTGGTGTTTTGTATAAAAACACTCCGAAAGAGAAAAAAATTGGCGAATTAGAAAGCTGGGAATATGTAAAAGTAAAGGGCAAAATTCTCAAATCTTTTGGATTAATTAGTTATTCGAAAGGGAAATTCCAACCTATTATTTTAGGAGACGAAACCGGTACTATTAAAGCTATTATTTGGAATACCGATAAAGAATTACCTGAAAACACTGTAATAGAAGCTATTGGGAAAACCAAAATTAATAAGAAAACTGGCAATTTAGAATTACATATAGACAGTTATAAAATTTTAGAAAGCGATTTAGAGATAAAACCCCAAAAGCAAGAATTTGTTGGGATTTGCATAGTTAAATATCCAAAAAAACAAACCCAAAAAGGCACAATAGTATCGAAAGCAATTTTAACTAGCTTAGATAGGGAATTGCCTGTAGTATATTTCAACGATTTTGATTGGGAAATAGGCCATATATATAAAGTATATGGAAAGCTTAAGAAAAACATAAAAACTGGTAAAATAGAATTTTTCGCTGACAAAGTTGAGGAAGCAACATTAAAAGATCTAAAAGCTTTTAAAGGAGAGGCCGATGGAAGCGGAGGGGTCGACTTGAAAAACAAGCTCGTCTTAATTGACGGCAACAGCGTGGCGTACCGCGCCTTTTTTGCGTTGCCGCTTTTGCATAACGATAAAGGGATTCATACGAACGCAGTCTACGGGTTTACGATGATGTTAAACAAAATTTTGGCGGAAGAGCAGCCGACCCACATTCTCGTTGCGTTTGACGCCGGGAAAACGACGTTCCGCCATGAAACGTTCCAAGACGCCAAAGGCGGGCGGCAGCAGACGCCGCCGGAACTGTCGGAACAGTTTCCGCTCGTGCGCGAATTGCTCAAAGCGTACCGCATCCCCGCCTATGAGCTCGACCATTATGAAGCGGATGACATCATCGGAACGATGGCGGCGCGGGCTGAGCGAGAAGGGTTTGCAGTGAAAGTCATTTCCGGCGACCGCGATTTAACCCAGCTTGCTTCCCCGCAAGTGACGGTGGAGATTACGAAAAAAGGGATTACCGACATCGAGTCGTACACGCCGGAGACGGTCGTGGAAAAATACGGCCTCACCCCGGAGCAAATTGTCGACTTGAAAGGATTGATGGGCGACAAATCCGACAACATCCCTGGCGTGCCCGGCATCGGGAAAAAAACAGCCGTCAAGCTGCTCAAGCAATTCGGCACGGTCGAAAACGTACTGGCATCGATCGATGAGATCAAAGGGGAGAAGCTGAAAGAAAATTTGCGCCAATACCGGGATTTGGCGCTTTTAAGCAAACAGCTGGCCGCTATTTGCCGCGACGCCCCGGTTGAGCTGACGCTCGATGACATTGTCTACAAAGGAGAAGACCGGGAAAAAGTGGTCGCCTTGTTTCAGGAGCTCGGATTCCAGTCGTTTCTCGACAAGATGGCCGTCCAAACGGATGAAGGCGAAAAGCCGCTCGCCGGGATGGATTTTGCGATCGCCGACAGCGTCACGGACGAAATGCTCGCCGACAAAGCGGCCCTCGTCGTGGAGGTGGTGGGCGACAACTATCACCATGCCCCGATTGTCGGGATCGCCTTGGCCAACGAACGCGGGCGGTTTTTCCTGCGCCCGGAGACGGCCGTCGCCGATCCGAAATTTCTCGCTTGGCTTGGCGATGAGACGAAGAAAAAAACGATGTTTGATTCAAAGCGGGCGGCCGTCGCGCTAAATGGGAAAGGAATCGAACTGGCTGGCGTCGGCGTCGTGTTCGATCTGTTGCTGGCCGCTTACTTGCTCGATCCGGCGCAGGCGGCGGGCGACGTTGCCGCGGTGGCGAAAATGCATCAGTACGAGGCGGTGCGATCGGATGAGGCGGTCTATGGAAAAGGAGCGAAGCGGACGGTTCCTGATGAACCGACGCTTGCCGAGCAGCTCGTCCGCAAGGCGGCGGCCATTTGGGCGCTTGAAGAGCCGTTGATGGACGAACTGCGCCGCAACGAACAAGATCGGCTGCTGACCGAGCTCGAACACGCGCTGGCTGGCATTTTGGCCAATATGGAATTTACTGGAGTGAAAGTGGACACGAAGCGGCTTGAACAGATGGGGGCGGAGCTCACCGAGCAGCTGCAGGCGGTCGAGCGGCGCATTTACGAACTCGCCGGCCAAGAGTTCAACATTAACTCGCCGAAACAGCTCGGGACGGTTTTATTTGACAAGCTGCAGCTCCCGGTGTTGAAAAAGACAAAAACCGGCTATTCGACTTCAGCCGATGTGCTAGAAAAGCTTGCACCGCACCATGAAATCGTCGAACATATTTTGCATTACCGCCAACTCGGCAAGCTGCAGTCAACGTATATTGAAGGGCTGCTGAAAGTGGTGCACCCCGTGACGGGCAAAGTGCACACGATGTTCAATCAGGCGTTGACGCAAACCGGGCGCCTCAGCTCCGTCGAACCGAATTTGCAAAACATTCCGATTCGGCTTGAGGAAGGGCGGAAAATCCGCCAGGCGTTCGTGCCGTCGGAGCCGGACTGGCTCATCTTTGCGGCCGACTATTCGCAAATCGAGCTGCGCGTCCTCGCCCATATCGCGGAAGATGACAATTTGATTGAAGCGTTCCGGCGCTGGTTGGACATCCATACGAAAACAGCCATGGACATTTTCCATGTGAGCGAAGAAGACGTGACAGCCAACATGCGCCGCCAAGCGAAGGCCGTCAATTTTGGCATCGTGTACGGCATTAGTGATTACGGTCTGGCGCAAAACTTGAACATTACGCGCAAAGAAGCGGCTGAATTTATTGAGCGATATTTTGCCAGTTTTCCAGGTGTAAAGCAATATATGGACAACATTGTGCAAGAAGCGAAACAAAAAGGGTATGTGACGACGCTGCTGCATCGGCGCCGCTATTTGCCCGATATTACAAGCCGCAACTTCAACGTCCGCACGTTCGCCGAGCGGACGGCGATGAACACACCGATCCAGGGATCCGCTGCCGACATCATTAAGAAAGCGATGATCGATCTAAGCGTGAGCGTGCGCGAAGAACGGCTGCAGGCGCGCCTGTTGCTGCAAGGTCATGACGAACTCATTTTGGAGGCGCCGAAAGAGGAAATCGGACGGCTGTGCCGCCTCGTTCCGGAAGTGATGGAGCAAGCCGTGACACTTCGCGTGCCGCTGAAAGTCGATTACCATTACGGTCCGACGTGGTACGACGCCAAATAA
长度:3384核苷酸
类型:核酸
拓扑结构:质粒
链的数量:1条
分子类型:DNA
SEQ.5.
ATGGATGAAGAGGAACTAATACAACTAATAATAGAAAAAACTGGCAAATCTCGAGAGGAAATAGAAAAAATGGTGGAAGAAAAAATTAAAGCTTTTAACAATTTAATATCTCGTAGGGGGGCTTTACTATTAGTAGCAAAAAAACTTGGTGTTTTGTATAAAAACACTCCGAAAGAGAAAAAAATTGGCGAATTAGAAAGCTGGGAATATGTAAAAGTAAAGGGCAAAATTCTCAAATCTTTTGGATTAATTAGTTATTCGAAAGGGAAATTCCAACCTATTATTTTAGGAGACGAAACCGGTACTATTAAAGCTATTATTTGGAATACCGATAAAGAATTACCTGAAAACACTGTAATAGAAGCTATTGGGAAAACCAAAATTAATAAGAAAACTGGCAATTTAGAATTACATATAGACAGTTATAAAATTTTAGAAAGCGATTTAGAGATAAAACCCCAAAAGCAAGAATTTGTTGGGATTTGCATAGTTAAATATCCAAAAAAACAAACCCAAAAAGGCACAATAGTATCGAAAGCAATTTTAACTAGCTTAGATAGGGAATTGCCTGTAGTATATTTCAACGATTTTGATTGGGAAATAGGCCATATATATAAAGTATATGGAAAGCTTAAGAAAAACATAAAAACTGGTAAAATAGAATTTTTCGCTGACAAAGTTGAGGAAGCAACATTAAAAGATCTAAAAGCTTTTAAAGGAGAGGCCGATGGAAGCGGAGGGGTCGACTTGGCCGACAAAGCGGCCCTCGTCGTGGAGGTGGTGGGCGACAACTATCACCATGCCCCGATTGTCGGGATCGCCTTGGCCAACGAACGCGGGCGGTTTTTCCTGCGCCCGGAGACGGCCGTCGCCGATCCGAAATTTCTCGCTTGGCTTGGCGATGAGACGAAGAAAAAAACGATGTTTGATTCAAAGCGGGCGGCCGTCGCGCTAAATGGGAAAGGAATCGAACTGGCTGGCGTCGGCGTCGTGTTCGATCTGTTGCTGGCCGCTTACTTGCTCGATCCGGCGCAGGCGGCGGGCGACGTTGCCGCGGTGGCGAAAATGCATCAGTACGAGGCGGTGCGATCGGATGAGGCGGTCTATGGAAAAGGAGCGAAGCGGACGGTTCCTGATGAACCGACGCTTGCCGAGCAGCTCGTCCGCAAGGCGGCGGCCATTTGGGCGCTTGAAGAGCCGTTGATGGACGAACTGCGCCGCAACGAACAAGATCGGCTGCTGACCGAGCTCGAACACGCGCTGGCTGGCATTTTGGCCAATATGGAATTTACTGGAGTGAAAGTGGACACGAAGCGGCTTGAACAGATGGGGGCGGAGCTCACCGAGCAGCTGCAGGCGGTCGAGCGGCGCATTTACGAACTCGCCGGCCAAGAGTTCAACATTAACTCGCCGAAACAGCTCGGGACGGTTTTATTTGACAAGCTGCAGCTCCCGGTGTTGAAAAAGACAAAAACCGGCTATTCGACTTCAGCCGATGTGCTAGAAAAGCTTGCACCGCACCATGAAATCGTCGAACATATTTTGCATTACCGCCAACTCGGCAAGCTGCAGTCAACGTATATTGAAGGGCTGCTGAAAGTGGTGCACCCCGTGACGGGCAAAGTGCACACGATGTTCAATCAGGCGTTGACGCAAACCGGGCGCCTCAGCTCCGTCGAACCGAATTTGCAAAACATTCCGATTCGGCTTGAGGAAGGGCGGAAAATCCGCCAGGCGTTCGTGCCGTCGGAGCCGGACTGGCTCATCTTTGCGGCCGACTATTCGCAAATCGAGCTGCGCGTCCTCGCCCATATCGCGGAAGATGACAATTTGATTGAAGCGTTCCGGCGCTGGTTGGACATCCATACGAAAACAGCCATGGACATTTTCCATGTGAGCGAAGAAGACGTGACAGCCAACATGCGCCGCCAAGCGAAGGCCGTCAATTTTGGCATCGTGTACGGCATTAGTGATTACGGTCTGGCGCAAAACTTGAACATTACGCGCAAAGAAGCGGCTGAATTTATTGAGCGATATTTTGCCAGTTTTCCAGGTGTAAAGCAATATATGGACAACATTGTGCAAGAAGCGAAACAAAAAGGGTATGTGACGACGCTGCTGCATCGGCGCCGCTATTTGCCCGATATTACAAGCCGCAACTTCAACGTCCGCACGTTCGCCGAGCGGACGGCGATGAACACACCGATCCAGGGATCCGCTGCCGACATCATTAAGAAAGCGATGATCGATCTAAGCGTGAGCGTGCGCGAAGAACGGCTGCAGGCGCGCCTGTTGCTGCAAGGTCATGACGAACTCATTTTGGAGGCGCCGAAAGAGGAAATCGGACGGCTGTGCCGCCTCGTTCCGGAAGTGATGGAGCAAGCCGTGACACTTCGCGTGCCGCTGAAAGTCGATTACCATTACGGTCCGACGTGGTACGACGCCAAATAA
长度:2451核苷酸
类型:核酸
拓扑结构:质粒
链的数量:1条
分子类型:DNA
SEQ.6.
ATGGATGAAGAGGAACTAATACAACTAATAATAGAAAAAACTGGCAAATCTCGAGAGGAAATAGAAAAAATGGTGGAAGAAAAAATTAAAGCTTTTAACAATTTAATATCTCGTAGGGGGGCTTTACTATTAGTAGCAAAAAAACTTGGTGTTTTGTATAAAAACACTCCGAAAGAGAAAAAAATTGGCGAATTAGAAAGCTGGGAATATGTAAAAGTAAAGGGCAAAATTCTCAAATCTTTTGGATTAATTAGTTATTCGAAAGGGAAATTCCAACCTATTATTTTAGGAGACGAAACCGGTACTATTAAAGCTATTATTTGGAATACCGATAAAGAATTACCTGAAAACACTGTAATAGAAGCTATTGGGAAAACCAAAATTAATAAGAAAACTGGCAATTTAGAATTACATATAGACAGTTATAAAATTTTAGAAAGCGATTTAGAGATAAAACCCCAAAAGCAAGAATTTGTTGGGATTTGCATAGTTAAATATCCAAAAAAACAAACCCAAAAAGGCACAATAGTATCGAAAGCAATTTTAACTAGCTTAGATAGGGAATTGCCTGTAGTATATTTCAACGATTTTGATTGGGAAATAGGCCATATATATAAAGTATATGGAAAGCTTAAGAAAAACATAAAAACTGGTAAAATAGAATTTTTCGCTGACAAAGTTGAGGAAGCAACATTAAAAGATCTAAAAGCTTTTAAAGGAGAGGCCGATGGAAGCGGAGGGGTCGACTTGGAACTGCGCCGCAACGAACAAGATCGGCTGCTGACCGAGCTCGAACACGCGCTGGCTGGCATTTTGGCCAATATGGAATTTACTGGAGTGAAAGTGGACACGAAGCGGCTTGAACAGATGGGGGCGGAGCTCACCGAGCAGCTGCAGGCGGTCGAGCGGCGCATTTACGAACTCGCCGGCCAAGAGTTCAACATTAACTCGCCGAAACAGCTCGGGACGGTTTTATTTGACAAGCTGCAGCTCCCGGTGTTGAAAAAGACAAAAACCGGCTATTCGACTTCAGCCGATGTGCTAGAAAAGCTTGCACCGCACCATGAAATCGTCGAACATATTTTGCATTACCGCCAACTCGGCAAGCTGCAGTCAACGTATATTGAAGGGCTGCTGAAAGTGGTGCACCCCGTGACGGGCAAAGTGCACACGATGTTCAATCAGGCGTTGACGCAAACCGGGCGCCTCAGCTCCGTCGAACCGAATTTGCAAAACATTCCGATTCGGCTTGAGGAAGGGCGGAAAATCCGCCAGGCGTTCGTGCCGTCGGAGCCGGACTGGCTCATCTTTGCGGCCGACTATTCGCAAATCGAGCTGCGCGTCCTCGCCCATATCGCGGAAGATGACAATTTGATTGAAGCGTTCCGGCGCTGGTTGGACATCCATACGAAAACAGCCATGGACATTTTCCATGTGAGCGAAGAAGACGTGACAGCCAACATGCGCCGCCAAGCGAAGGCCGTCAATTTTGGCATCGTGTACGGCATTAGTGATTACGGTCTGGCGCAAAACTTGAACATTACGCGCAAAGAAGCGGCTGAATTTATTGAGCGATATTTTGCCAGTTTTCCAGGTGTAAAGCAATATATGGACAACATTGTGCAAGAAGCGAAACAAAAAGGGTATGTGACGACGCTGCTGCATCGGCGCCGCTATTTGCCCGATATTACAAGCCGCAACTTCAACGTCCGCACGTTCGCCGAGCGGACGGCGATGAACACACCGATCCAGGGATCCGCTGCCGACATCATTAAGAAAGCGATGATCGATCTAAGCGTGAGCGTGCGCGAAGAACGGCTGCAGGCGCGCCTGTTGCTGCAAGGTCATGACGAACTCATTTTGGAGGCGCCGAAAGAGGAAATCGGACGGCTGTGCCGCCTCGTTCCGGAAGTGATGGAGCAAGCCGTGACACTTCGCGTGCCGCTGAAAGTCGATTACCATTACGGTCCGACGTGGTACGACGCCAAATAA
长度:1992核苷酸
类型:核酸
拓扑结构:质粒
链的数量:1条
分子类型:DNA
序列表
<110> 生物技术与分子医学研究所
<120> 融合单链DNA聚合酶Bst、编码融合DNA聚合酶NeqSSB-Bst的核酸分子、其制备方法和用途
<130> 2PCT/MM/2019
<140> PCT/PL2019/000046
<141> 2019-06-26
<150> P.426093
<151> 2018-06-27
<160> 6
<170> PatentIn version 3.5
<210> 1
<211> 1127
<212> PRT
<213> 智人
<400> 1
Met Asp Glu Glu Glu Leu Ile Gln Leu Ile Ile Glu Lys Thr Gly Lys
1 5 10 15
Ser Arg Glu Glu Ile Glu Lys Met Val Glu Glu Lys Ile Lys Ala Phe
20 25 30
Asn Asn Leu Ile Ser Arg Arg Gly Ala Leu Leu Leu Val Ala Lys Lys
35 40 45
Leu Gly Val Leu Tyr Lys Asn Thr Pro Lys Glu Lys Lys Ile Gly Glu
50 55 60
Leu Glu Ser Trp Glu Tyr Val Lys Val Lys Gly Lys Ile Leu Lys Ser
65 70 75 80
Phe Gly Leu Ile Ser Tyr Ser Lys Gly Lys Phe Gln Pro Ile Ile Leu
85 90 95
Gly Asp Glu Thr Gly Thr Ile Lys Ala Ile Ile Trp Asn Thr Asp Lys
100 105 110
Glu Leu Pro Glu Asn Thr Val Ile Glu Ala Ile Gly Lys Thr Lys Ile
115 120 125
Asn Lys Lys Thr Gly Asn Leu Glu Leu His Ile Asp Ser Tyr Lys Ile
130 135 140
Leu Glu Ser Asp Leu Glu Ile Lys Pro Gln Lys Gln Glu Phe Val Gly
145 150 155 160
Ile Cys Ile Val Lys Tyr Pro Lys Lys Gln Thr Gln Lys Gly Thr Ile
165 170 175
Val Ser Lys Ala Ile Leu Thr Ser Leu Asp Arg Glu Leu Pro Val Val
180 185 190
Tyr Phe Asn Asp Phe Asp Trp Glu Ile Gly His Ile Tyr Lys Val Tyr
195 200 205
Gly Lys Leu Lys Lys Asn Ile Lys Thr Gly Lys Ile Glu Phe Phe Ala
210 215 220
Asp Lys Val Glu Glu Ala Thr Leu Lys Asp Leu Lys Ala Phe Lys Gly
225 230 235 240
Glu Ala Asp Gly Ser Gly Gly Val Asp Leu Lys Asn Lys Leu Val Leu
245 250 255
Ile Asp Gly Asn Ser Val Ala Tyr Arg Ala Phe Phe Ala Leu Pro Leu
260 265 270
Leu His Asn Asp Lys Gly Ile His Thr Asn Ala Val Tyr Gly Phe Thr
275 280 285
Met Met Leu Asn Lys Ile Leu Ala Glu Glu Gln Pro Thr His Ile Leu
290 295 300
Val Ala Phe Asp Ala Gly Lys Thr Thr Phe Arg His Glu Thr Phe Gln
305 310 315 320
Asp Ala Lys Gly Gly Arg Gln Gln Thr Pro Pro Glu Leu Ser Glu Gln
325 330 335
Phe Pro Leu Val Arg Glu Leu Leu Lys Ala Tyr Arg Ile Pro Ala Tyr
340 345 350
Glu Leu Asp His Tyr Glu Ala Asp Asp Ile Ile Gly Thr Met Ala Ala
355 360 365
Arg Ala Glu Arg Glu Gly Phe Ala Val Lys Val Ile Ser Gly Asp Arg
370 375 380
Asp Leu Thr Gln Leu Ala Ser Pro Gln Val Thr Val Glu Ile Thr Lys
385 390 395 400
Lys Gly Ile Thr Asp Ile Glu Ser Tyr Thr Pro Glu Thr Val Val Glu
405 410 415
Lys Tyr Gly Leu Thr Pro Glu Gln Ile Val Asp Leu Lys Gly Leu Met
420 425 430
Gly Asp Lys Ser Asp Asn Ile Pro Gly Val Pro Gly Ile Gly Lys Lys
435 440 445
Thr Ala Val Lys Leu Leu Lys Gln Phe Gly Thr Val Glu Asn Val Leu
450 455 460
Ala Ser Ile Asp Glu Ile Lys Gly Glu Lys Leu Lys Glu Asn Leu Arg
465 470 475 480
Gln Tyr Arg Asp Leu Ala Leu Leu Ser Lys Gln Leu Ala Ala Ile Cys
485 490 495
Arg Asp Ala Pro Val Glu Leu Thr Leu Asp Asp Ile Val Tyr Lys Gly
500 505 510
Glu Asp Arg Glu Lys Val Val Ala Leu Phe Gln Glu Leu Gly Phe Gln
515 520 525
Ser Phe Leu Asp Lys Met Ala Val Gln Thr Asp Glu Gly Glu Lys Pro
530 535 540
Leu Ala Gly Met Asp Phe Ala Ile Ala Asp Ser Val Thr Asp Glu Met
545 550 555 560
Leu Ala Asp Lys Ala Ala Leu Val Val Glu Val Val Gly Asp Asn Tyr
565 570 575
His His Ala Pro Ile Val Gly Ile Ala Leu Ala Asn Glu Arg Gly Arg
580 585 590
Phe Phe Leu Arg Pro Glu Thr Ala Val Ala Asp Pro Lys Phe Leu Ala
595 600 605
Trp Leu Gly Asp Glu Thr Lys Lys Lys Thr Met Phe Asp Ser Lys Arg
610 615 620
Ala Ala Val Ala Leu Asn Gly Lys Gly Ile Glu Leu Ala Gly Val Gly
625 630 635 640
Val Val Phe Asp Leu Leu Leu Ala Ala Tyr Leu Leu Asp Pro Ala Gln
645 650 655
Ala Ala Gly Asp Val Ala Ala Val Ala Lys Met His Gln Tyr Glu Ala
660 665 670
Val Arg Ser Asp Glu Ala Val Tyr Gly Lys Gly Ala Lys Arg Thr Val
675 680 685
Pro Asp Glu Pro Thr Leu Ala Glu Gln Leu Val Arg Lys Ala Ala Ala
690 695 700
Ile Trp Ala Leu Glu Glu Pro Leu Met Asp Glu Leu Arg Arg Asn Glu
705 710 715 720
Gln Asp Arg Leu Leu Thr Glu Leu Glu His Ala Leu Ala Gly Ile Leu
725 730 735
Ala Asn Met Glu Phe Thr Gly Val Lys Val Asp Thr Lys Arg Leu Glu
740 745 750
Gln Met Gly Ala Glu Leu Thr Glu Gln Leu Gln Ala Val Glu Arg Arg
755 760 765
Ile Tyr Glu Leu Ala Gly Gln Glu Phe Asn Ile Asn Ser Pro Lys Gln
770 775 780
Leu Gly Thr Val Leu Phe Asp Lys Leu Gln Leu Pro Val Leu Lys Lys
785 790 795 800
Thr Lys Thr Gly Tyr Ser Thr Ser Ala Asp Val Leu Glu Lys Leu Ala
805 810 815
Pro His His Glu Ile Val Glu His Ile Leu His Tyr Arg Gln Leu Gly
820 825 830
Lys Leu Gln Ser Thr Tyr Ile Glu Gly Leu Leu Lys Val Val His Pro
835 840 845
Val Thr Gly Lys Val His Thr Met Phe Asn Gln Ala Leu Thr Gln Thr
850 855 860
Gly Arg Leu Ser Ser Val Glu Pro Asn Leu Gln Asn Ile Pro Ile Arg
865 870 875 880
Leu Glu Glu Gly Arg Lys Ile Arg Gln Ala Phe Val Pro Ser Glu Pro
885 890 895
Asp Trp Leu Ile Phe Ala Ala Asp Tyr Ser Gln Ile Glu Leu Arg Val
900 905 910
Leu Ala His Ile Ala Glu Asp Asp Asn Leu Ile Glu Ala Phe Arg Arg
915 920 925
Trp Leu Asp Ile His Thr Lys Thr Ala Met Asp Ile Phe His Val Ser
930 935 940
Glu Glu Asp Val Thr Ala Asn Met Arg Arg Gln Ala Lys Ala Val Asn
945 950 955 960
Phe Gly Ile Val Tyr Gly Ile Ser Asp Tyr Gly Leu Ala Gln Asn Leu
965 970 975
Asn Ile Thr Arg Lys Glu Ala Ala Glu Phe Ile Glu Arg Tyr Phe Ala
980 985 990
Ser Phe Pro Gly Val Lys Gln Tyr Met Asp Asn Ile Val Gln Glu Ala
995 1000 1005
Lys Gln Lys Gly Tyr Val Thr Thr Leu Leu His Arg Arg Arg Tyr
1010 1015 1020
Leu Pro Asp Ile Thr Ser Arg Asn Phe Asn Val Arg Thr Phe Ala
1025 1030 1035
Glu Arg Thr Ala Met Asn Thr Pro Ile Gln Gly Ser Ala Ala Asp
1040 1045 1050
Ile Ile Lys Lys Ala Met Ile Asp Leu Ser Val Ser Val Arg Glu
1055 1060 1065
Glu Arg Leu Gln Ala Arg Leu Leu Leu Gln Gly His Asp Glu Leu
1070 1075 1080
Ile Leu Glu Ala Pro Lys Glu Glu Ile Gly Arg Leu Cys Arg Leu
1085 1090 1095
Val Pro Glu Val Met Glu Gln Ala Val Thr Leu Arg Val Pro Leu
1100 1105 1110
Lys Val Asp Tyr His Tyr Gly Pro Thr Trp Tyr Asp Ala Lys
1115 1120 1125
<210> 2
<211> 816
<212> PRT
<213> 智人
<400> 2
Met Asp Glu Glu Glu Leu Ile Gln Leu Ile Ile Glu Lys Thr Gly Lys
1 5 10 15
Ser Arg Glu Glu Ile Glu Lys Met Val Glu Glu Lys Ile Lys Ala Phe
20 25 30
Asn Asn Leu Ile Ser Arg Arg Gly Ala Leu Leu Leu Val Ala Lys Lys
35 40 45
Leu Gly Val Leu Tyr Lys Asn Thr Pro Lys Glu Lys Lys Ile Gly Glu
50 55 60
Leu Glu Ser Trp Glu Tyr Val Lys Val Lys Gly Lys Ile Leu Lys Ser
65 70 75 80
Phe Gly Leu Ile Ser Tyr Ser Lys Gly Lys Phe Gln Pro Ile Ile Leu
85 90 95
Gly Asp Glu Thr Gly Thr Ile Lys Ala Ile Ile Trp Asn Thr Asp Lys
100 105 110
Glu Leu Pro Glu Asn Thr Val Ile Glu Ala Ile Gly Lys Thr Lys Ile
115 120 125
Asn Lys Lys Thr Gly Asn Leu Glu Leu His Ile Asp Ser Tyr Lys Ile
130 135 140
Leu Glu Ser Asp Leu Glu Ile Lys Pro Gln Lys Gln Glu Phe Val Gly
145 150 155 160
Ile Cys Ile Val Lys Tyr Pro Lys Lys Gln Thr Gln Lys Gly Thr Ile
165 170 175
Val Ser Lys Ala Ile Leu Thr Ser Leu Asp Arg Glu Leu Pro Val Val
180 185 190
Tyr Phe Asn Asp Phe Asp Trp Glu Ile Gly His Ile Tyr Lys Val Tyr
195 200 205
Gly Lys Leu Lys Lys Asn Ile Lys Thr Gly Lys Ile Glu Phe Phe Ala
210 215 220
Asp Lys Val Glu Glu Ala Thr Leu Lys Asp Leu Lys Ala Phe Lys Gly
225 230 235 240
Glu Ala Asp Gly Ser Gly Gly Val Asp Leu Ala Asp Lys Ala Ala Leu
245 250 255
Val Val Glu Val Val Gly Asp Asn Tyr His His Ala Pro Ile Val Gly
260 265 270
Ile Ala Leu Ala Asn Glu Arg Gly Arg Phe Phe Leu Arg Pro Glu Thr
275 280 285
Ala Val Ala Asp Pro Lys Phe Leu Ala Trp Leu Gly Asp Glu Thr Lys
290 295 300
Lys Lys Thr Met Phe Asp Ser Lys Arg Ala Ala Val Ala Leu Asn Gly
305 310 315 320
Lys Gly Ile Glu Leu Ala Gly Val Gly Val Val Phe Asp Leu Leu Leu
325 330 335
Ala Ala Tyr Leu Leu Asp Pro Ala Gln Ala Ala Gly Asp Val Ala Ala
340 345 350
Val Ala Lys Met His Gln Tyr Glu Ala Val Arg Ser Asp Glu Ala Val
355 360 365
Tyr Gly Lys Gly Ala Lys Arg Thr Val Pro Asp Glu Pro Thr Leu Ala
370 375 380
Glu Gln Leu Val Arg Lys Ala Ala Ala Ile Trp Ala Leu Glu Glu Pro
385 390 395 400
Leu Met Asp Glu Leu Arg Arg Asn Glu Gln Asp Arg Leu Leu Thr Glu
405 410 415
Leu Glu His Ala Leu Ala Gly Ile Leu Ala Asn Met Glu Phe Thr Gly
420 425 430
Val Lys Val Asp Thr Lys Arg Leu Glu Gln Met Gly Ala Glu Leu Thr
435 440 445
Glu Gln Leu Gln Ala Val Glu Arg Arg Ile Tyr Glu Leu Ala Gly Gln
450 455 460
Glu Phe Asn Ile Asn Ser Pro Lys Gln Leu Gly Thr Val Leu Phe Asp
465 470 475 480
Lys Leu Gln Leu Pro Val Leu Lys Lys Thr Lys Thr Gly Tyr Ser Thr
485 490 495
Ser Ala Asp Val Leu Glu Lys Leu Ala Pro His His Glu Ile Val Glu
500 505 510
His Ile Leu His Tyr Arg Gln Leu Gly Lys Leu Gln Ser Thr Tyr Ile
515 520 525
Glu Gly Leu Leu Lys Val Val His Pro Val Thr Gly Lys Val His Thr
530 535 540
Met Phe Asn Gln Ala Leu Thr Gln Thr Gly Arg Leu Ser Ser Val Glu
545 550 555 560
Pro Asn Leu Gln Asn Ile Pro Ile Arg Leu Glu Glu Gly Arg Lys Ile
565 570 575
Arg Gln Ala Phe Val Pro Ser Glu Pro Asp Trp Leu Ile Phe Ala Ala
580 585 590
Asp Tyr Ser Gln Ile Glu Leu Arg Val Leu Ala His Ile Ala Glu Asp
595 600 605
Asp Asn Leu Ile Glu Ala Phe Arg Arg Trp Leu Asp Ile His Thr Lys
610 615 620
Thr Ala Met Asp Ile Phe His Val Ser Glu Glu Asp Val Thr Ala Asn
625 630 635 640
Met Arg Arg Gln Ala Lys Ala Val Asn Phe Gly Ile Val Tyr Gly Ile
645 650 655
Ser Asp Tyr Gly Leu Ala Gln Asn Leu Asn Ile Thr Arg Lys Glu Ala
660 665 670
Ala Glu Phe Ile Glu Arg Tyr Phe Ala Ser Phe Pro Gly Val Lys Gln
675 680 685
Tyr Met Asp Asn Ile Val Gln Glu Ala Lys Gln Lys Gly Tyr Val Thr
690 695 700
Thr Leu Leu His Arg Arg Arg Tyr Leu Pro Asp Ile Thr Ser Arg Asn
705 710 715 720
Phe Asn Val Arg Thr Phe Ala Glu Arg Thr Ala Met Asn Thr Pro Ile
725 730 735
Gln Gly Ser Ala Ala Asp Ile Ile Lys Lys Ala Met Ile Asp Leu Ser
740 745 750
Val Ser Val Arg Glu Glu Arg Leu Gln Ala Arg Leu Leu Leu Gln Gly
755 760 765
His Asp Glu Leu Ile Leu Glu Ala Pro Lys Glu Glu Ile Gly Arg Leu
770 775 780
Cys Arg Leu Val Pro Glu Val Met Glu Gln Ala Val Thr Leu Arg Val
785 790 795 800
Pro Leu Lys Val Asp Tyr His Tyr Gly Pro Thr Trp Tyr Asp Ala Lys
805 810 815
<210> 3
<211> 663
<212> PRT
<213> 智人
<400> 3
Met Asp Glu Glu Glu Leu Ile Gln Leu Ile Ile Glu Lys Thr Gly Lys
1 5 10 15
Ser Arg Glu Glu Ile Glu Lys Met Val Glu Glu Lys Ile Lys Ala Phe
20 25 30
Asn Asn Leu Ile Ser Arg Arg Gly Ala Leu Leu Leu Val Ala Lys Lys
35 40 45
Leu Gly Val Leu Tyr Lys Asn Thr Pro Lys Glu Lys Lys Ile Gly Glu
50 55 60
Leu Glu Ser Trp Glu Tyr Val Lys Val Lys Gly Lys Ile Leu Lys Ser
65 70 75 80
Phe Gly Leu Ile Ser Tyr Ser Lys Gly Lys Phe Gln Pro Ile Ile Leu
85 90 95
Gly Asp Glu Thr Gly Thr Ile Lys Ala Ile Ile Trp Asn Thr Asp Lys
100 105 110
Glu Leu Pro Glu Asn Thr Val Ile Glu Ala Ile Gly Lys Thr Lys Ile
115 120 125
Asn Lys Lys Thr Gly Asn Leu Glu Leu His Ile Asp Ser Tyr Lys Ile
130 135 140
Leu Glu Ser Asp Leu Glu Ile Lys Pro Gln Lys Gln Glu Phe Val Gly
145 150 155 160
Ile Cys Ile Val Lys Tyr Pro Lys Lys Gln Thr Gln Lys Gly Thr Ile
165 170 175
Val Ser Lys Ala Ile Leu Thr Ser Leu Asp Arg Glu Leu Pro Val Val
180 185 190
Tyr Phe Asn Asp Phe Asp Trp Glu Ile Gly His Ile Tyr Lys Val Tyr
195 200 205
Gly Lys Leu Lys Lys Asn Ile Lys Thr Gly Lys Ile Glu Phe Phe Ala
210 215 220
Asp Lys Val Glu Glu Ala Thr Leu Lys Asp Leu Lys Ala Phe Lys Gly
225 230 235 240
Glu Ala Asp Gly Ser Gly Gly Val Asp Leu Glu Leu Arg Arg Asn Glu
245 250 255
Gln Asp Arg Leu Leu Thr Glu Leu Glu His Ala Leu Ala Gly Ile Leu
260 265 270
Ala Asn Met Glu Phe Thr Gly Val Lys Val Asp Thr Lys Arg Leu Glu
275 280 285
Gln Met Gly Ala Glu Leu Thr Glu Gln Leu Gln Ala Val Glu Arg Arg
290 295 300
Ile Tyr Glu Leu Ala Gly Gln Glu Phe Asn Ile Asn Ser Pro Lys Gln
305 310 315 320
Leu Gly Thr Val Leu Phe Asp Lys Leu Gln Leu Pro Val Leu Lys Lys
325 330 335
Thr Lys Thr Gly Tyr Ser Thr Ser Ala Asp Val Leu Glu Lys Leu Ala
340 345 350
Pro His His Glu Ile Val Glu His Ile Leu His Tyr Arg Gln Leu Gly
355 360 365
Lys Leu Gln Ser Thr Tyr Ile Glu Gly Leu Leu Lys Val Val His Pro
370 375 380
Val Thr Gly Lys Val His Thr Met Phe Asn Gln Ala Leu Thr Gln Thr
385 390 395 400
Gly Arg Leu Ser Ser Val Glu Pro Asn Leu Gln Asn Ile Pro Ile Arg
405 410 415
Leu Glu Glu Gly Arg Lys Ile Arg Gln Ala Phe Val Pro Ser Glu Pro
420 425 430
Asp Trp Leu Ile Phe Ala Ala Asp Tyr Ser Gln Ile Glu Leu Arg Val
435 440 445
Leu Ala His Ile Ala Glu Asp Asp Asn Leu Ile Glu Ala Phe Arg Arg
450 455 460
Trp Leu Asp Ile His Thr Lys Thr Ala Met Asp Ile Phe His Val Ser
465 470 475 480
Glu Glu Asp Val Thr Ala Asn Met Arg Arg Gln Ala Lys Ala Val Asn
485 490 495
Phe Gly Ile Val Tyr Gly Ile Ser Asp Tyr Gly Leu Ala Gln Asn Leu
500 505 510
Asn Ile Thr Arg Lys Glu Ala Ala Glu Phe Ile Glu Arg Tyr Phe Ala
515 520 525
Ser Phe Pro Gly Val Lys Gln Tyr Met Asp Asn Ile Val Gln Glu Ala
530 535 540
Lys Gln Lys Gly Tyr Val Thr Thr Leu Leu His Arg Arg Arg Tyr Leu
545 550 555 560
Pro Asp Ile Thr Ser Arg Asn Phe Asn Val Arg Thr Phe Ala Glu Arg
565 570 575
Thr Ala Met Asn Thr Pro Ile Gln Gly Ser Ala Ala Asp Ile Ile Lys
580 585 590
Lys Ala Met Ile Asp Leu Ser Val Ser Val Arg Glu Glu Arg Leu Gln
595 600 605
Ala Arg Leu Leu Leu Gln Gly His Asp Glu Leu Ile Leu Glu Ala Pro
610 615 620
Lys Glu Glu Ile Gly Arg Leu Cys Arg Leu Val Pro Glu Val Met Glu
625 630 635 640
Gln Ala Val Thr Leu Arg Val Pro Leu Lys Val Asp Tyr His Tyr Gly
645 650 655
Pro Thr Trp Tyr Asp Ala Lys
660
<210> 4
<211> 3384
<212> DNA
<213> 智人
<400> 4
atggatgaag aggaactaat acaactaata atagaaaaaa ctggcaaatc tcgagaggaa 60
atagaaaaaa tggtggaaga aaaaattaaa gcttttaaca atttaatatc tcgtaggggg 120
gctttactat tagtagcaaa aaaacttggt gttttgtata aaaacactcc gaaagagaaa 180
aaaattggcg aattagaaag ctgggaatat gtaaaagtaa agggcaaaat tctcaaatct 240
tttggattaa ttagttattc gaaagggaaa ttccaaccta ttattttagg agacgaaacc 300
ggtactatta aagctattat ttggaatacc gataaagaat tacctgaaaa cactgtaata 360
gaagctattg ggaaaaccaa aattaataag aaaactggca atttagaatt acatatagac 420
agttataaaa ttttagaaag cgatttagag ataaaacccc aaaagcaaga atttgttggg 480
atttgcatag ttaaatatcc aaaaaaacaa acccaaaaag gcacaatagt atcgaaagca 540
attttaacta gcttagatag ggaattgcct gtagtatatt tcaacgattt tgattgggaa 600
ataggccata tatataaagt atatggaaag cttaagaaaa acataaaaac tggtaaaata 660
gaatttttcg ctgacaaagt tgaggaagca acattaaaag atctaaaagc ttttaaagga 720
gaggccgatg gaagcggagg ggtcgacttg aaaaacaagc tcgtcttaat tgacggcaac 780
agcgtggcgt accgcgcctt ttttgcgttg ccgcttttgc ataacgataa agggattcat 840
acgaacgcag tctacgggtt tacgatgatg ttaaacaaaa ttttggcgga agagcagccg 900
acccacattc tcgttgcgtt tgacgccggg aaaacgacgt tccgccatga aacgttccaa 960
gacgccaaag gcgggcggca gcagacgccg ccggaactgt cggaacagtt tccgctcgtg 1020
cgcgaattgc tcaaagcgta ccgcatcccc gcctatgagc tcgaccatta tgaagcggat 1080
gacatcatcg gaacgatggc ggcgcgggct gagcgagaag ggtttgcagt gaaagtcatt 1140
tccggcgacc gcgatttaac ccagcttgct tccccgcaag tgacggtgga gattacgaaa 1200
aaagggatta ccgacatcga gtcgtacacg ccggagacgg tcgtggaaaa atacggcctc 1260
accccggagc aaattgtcga cttgaaagga ttgatgggcg acaaatccga caacatccct 1320
ggcgtgcccg gcatcgggaa aaaaacagcc gtcaagctgc tcaagcaatt cggcacggtc 1380
gaaaacgtac tggcatcgat cgatgagatc aaaggggaga agctgaaaga aaatttgcgc 1440
caataccggg atttggcgct tttaagcaaa cagctggccg ctatttgccg cgacgccccg 1500
gttgagctga cgctcgatga cattgtctac aaaggagaag accgggaaaa agtggtcgcc 1560
ttgtttcagg agctcggatt ccagtcgttt ctcgacaaga tggccgtcca aacggatgaa 1620
ggcgaaaagc cgctcgccgg gatggatttt gcgatcgccg acagcgtcac ggacgaaatg 1680
ctcgccgaca aagcggccct cgtcgtggag gtggtgggcg acaactatca ccatgccccg 1740
attgtcggga tcgccttggc caacgaacgc gggcggtttt tcctgcgccc ggagacggcc 1800
gtcgccgatc cgaaatttct cgcttggctt ggcgatgaga cgaagaaaaa aacgatgttt 1860
gattcaaagc gggcggccgt cgcgctaaat gggaaaggaa tcgaactggc tggcgtcggc 1920
gtcgtgttcg atctgttgct ggccgcttac ttgctcgatc cggcgcaggc ggcgggcgac 1980
gttgccgcgg tggcgaaaat gcatcagtac gaggcggtgc gatcggatga ggcggtctat 2040
ggaaaaggag cgaagcggac ggttcctgat gaaccgacgc ttgccgagca gctcgtccgc 2100
aaggcggcgg ccatttgggc gcttgaagag ccgttgatgg acgaactgcg ccgcaacgaa 2160
caagatcggc tgctgaccga gctcgaacac gcgctggctg gcattttggc caatatggaa 2220
tttactggag tgaaagtgga cacgaagcgg cttgaacaga tgggggcgga gctcaccgag 2280
cagctgcagg cggtcgagcg gcgcatttac gaactcgccg gccaagagtt caacattaac 2340
tcgccgaaac agctcgggac ggttttattt gacaagctgc agctcccggt gttgaaaaag 2400
acaaaaaccg gctattcgac ttcagccgat gtgctagaaa agcttgcacc gcaccatgaa 2460
atcgtcgaac atattttgca ttaccgccaa ctcggcaagc tgcagtcaac gtatattgaa 2520
gggctgctga aagtggtgca ccccgtgacg ggcaaagtgc acacgatgtt caatcaggcg 2580
ttgacgcaaa ccgggcgcct cagctccgtc gaaccgaatt tgcaaaacat tccgattcgg 2640
cttgaggaag ggcggaaaat ccgccaggcg ttcgtgccgt cggagccgga ctggctcatc 2700
tttgcggccg actattcgca aatcgagctg cgcgtcctcg cccatatcgc ggaagatgac 2760
aatttgattg aagcgttccg gcgctggttg gacatccata cgaaaacagc catggacatt 2820
ttccatgtga gcgaagaaga cgtgacagcc aacatgcgcc gccaagcgaa ggccgtcaat 2880
tttggcatcg tgtacggcat tagtgattac ggtctggcgc aaaacttgaa cattacgcgc 2940
aaagaagcgg ctgaatttat tgagcgatat tttgccagtt ttccaggtgt aaagcaatat 3000
atggacaaca ttgtgcaaga agcgaaacaa aaagggtatg tgacgacgct gctgcatcgg 3060
cgccgctatt tgcccgatat tacaagccgc aacttcaacg tccgcacgtt cgccgagcgg 3120
acggcgatga acacaccgat ccagggatcc gctgccgaca tcattaagaa agcgatgatc 3180
gatctaagcg tgagcgtgcg cgaagaacgg ctgcaggcgc gcctgttgct gcaaggtcat 3240
gacgaactca ttttggaggc gccgaaagag gaaatcggac ggctgtgccg cctcgttccg 3300
gaagtgatgg agcaagccgt gacacttcgc gtgccgctga aagtcgatta ccattacggt 3360
ccgacgtggt acgacgccaa ataa 3384
<210> 5
<211> 2451
<212> DNA
<213> 智人
<400> 5
atggatgaag aggaactaat acaactaata atagaaaaaa ctggcaaatc tcgagaggaa 60
atagaaaaaa tggtggaaga aaaaattaaa gcttttaaca atttaatatc tcgtaggggg 120
gctttactat tagtagcaaa aaaacttggt gttttgtata aaaacactcc gaaagagaaa 180
aaaattggcg aattagaaag ctgggaatat gtaaaagtaa agggcaaaat tctcaaatct 240
tttggattaa ttagttattc gaaagggaaa ttccaaccta ttattttagg agacgaaacc 300
ggtactatta aagctattat ttggaatacc gataaagaat tacctgaaaa cactgtaata 360
gaagctattg ggaaaaccaa aattaataag aaaactggca atttagaatt acatatagac 420
agttataaaa ttttagaaag cgatttagag ataaaacccc aaaagcaaga atttgttggg 480
atttgcatag ttaaatatcc aaaaaaacaa acccaaaaag gcacaatagt atcgaaagca 540
attttaacta gcttagatag ggaattgcct gtagtatatt tcaacgattt tgattgggaa 600
ataggccata tatataaagt atatggaaag cttaagaaaa acataaaaac tggtaaaata 660
gaatttttcg ctgacaaagt tgaggaagca acattaaaag atctaaaagc ttttaaagga 720
gaggccgatg gaagcggagg ggtcgacttg gccgacaaag cggccctcgt cgtggaggtg 780
gtgggcgaca actatcacca tgccccgatt gtcgggatcg ccttggccaa cgaacgcggg 840
cggtttttcc tgcgcccgga gacggccgtc gccgatccga aatttctcgc ttggcttggc 900
gatgagacga agaaaaaaac gatgtttgat tcaaagcggg cggccgtcgc gctaaatggg 960
aaaggaatcg aactggctgg cgtcggcgtc gtgttcgatc tgttgctggc cgcttacttg 1020
ctcgatccgg cgcaggcggc gggcgacgtt gccgcggtgg cgaaaatgca tcagtacgag 1080
gcggtgcgat cggatgaggc ggtctatgga aaaggagcga agcggacggt tcctgatgaa 1140
ccgacgcttg ccgagcagct cgtccgcaag gcggcggcca tttgggcgct tgaagagccg 1200
ttgatggacg aactgcgccg caacgaacaa gatcggctgc tgaccgagct cgaacacgcg 1260
ctggctggca ttttggccaa tatggaattt actggagtga aagtggacac gaagcggctt 1320
gaacagatgg gggcggagct caccgagcag ctgcaggcgg tcgagcggcg catttacgaa 1380
ctcgccggcc aagagttcaa cattaactcg ccgaaacagc tcgggacggt tttatttgac 1440
aagctgcagc tcccggtgtt gaaaaagaca aaaaccggct attcgacttc agccgatgtg 1500
ctagaaaagc ttgcaccgca ccatgaaatc gtcgaacata ttttgcatta ccgccaactc 1560
ggcaagctgc agtcaacgta tattgaaggg ctgctgaaag tggtgcaccc cgtgacgggc 1620
aaagtgcaca cgatgttcaa tcaggcgttg acgcaaaccg ggcgcctcag ctccgtcgaa 1680
ccgaatttgc aaaacattcc gattcggctt gaggaagggc ggaaaatccg ccaggcgttc 1740
gtgccgtcgg agccggactg gctcatcttt gcggccgact attcgcaaat cgagctgcgc 1800
gtcctcgccc atatcgcgga agatgacaat ttgattgaag cgttccggcg ctggttggac 1860
atccatacga aaacagccat ggacattttc catgtgagcg aagaagacgt gacagccaac 1920
atgcgccgcc aagcgaaggc cgtcaatttt ggcatcgtgt acggcattag tgattacggt 1980
ctggcgcaaa acttgaacat tacgcgcaaa gaagcggctg aatttattga gcgatatttt 2040
gccagttttc caggtgtaaa gcaatatatg gacaacattg tgcaagaagc gaaacaaaaa 2100
gggtatgtga cgacgctgct gcatcggcgc cgctatttgc ccgatattac aagccgcaac 2160
ttcaacgtcc gcacgttcgc cgagcggacg gcgatgaaca caccgatcca gggatccgct 2220
gccgacatca ttaagaaagc gatgatcgat ctaagcgtga gcgtgcgcga agaacggctg 2280
caggcgcgcc tgttgctgca aggtcatgac gaactcattt tggaggcgcc gaaagaggaa 2340
atcggacggc tgtgccgcct cgttccggaa gtgatggagc aagccgtgac acttcgcgtg 2400
ccgctgaaag tcgattacca ttacggtccg acgtggtacg acgccaaata a 2451
<210> 6
<211> 1992
<212> DNA
<213> 智人
<400> 6
atggatgaag aggaactaat acaactaata atagaaaaaa ctggcaaatc tcgagaggaa 60
atagaaaaaa tggtggaaga aaaaattaaa gcttttaaca atttaatatc tcgtaggggg 120
gctttactat tagtagcaaa aaaacttggt gttttgtata aaaacactcc gaaagagaaa 180
aaaattggcg aattagaaag ctgggaatat gtaaaagtaa agggcaaaat tctcaaatct 240
tttggattaa ttagttattc gaaagggaaa ttccaaccta ttattttagg agacgaaacc 300
ggtactatta aagctattat ttggaatacc gataaagaat tacctgaaaa cactgtaata 360
gaagctattg ggaaaaccaa aattaataag aaaactggca atttagaatt acatatagac 420
agttataaaa ttttagaaag cgatttagag ataaaacccc aaaagcaaga atttgttggg 480
atttgcatag ttaaatatcc aaaaaaacaa acccaaaaag gcacaatagt atcgaaagca 540
attttaacta gcttagatag ggaattgcct gtagtatatt tcaacgattt tgattgggaa 600
ataggccata tatataaagt atatggaaag cttaagaaaa acataaaaac tggtaaaata 660
gaatttttcg ctgacaaagt tgaggaagca acattaaaag atctaaaagc ttttaaagga 720
gaggccgatg gaagcggagg ggtcgacttg gaactgcgcc gcaacgaaca agatcggctg 780
ctgaccgagc tcgaacacgc gctggctggc attttggcca atatggaatt tactggagtg 840
aaagtggaca cgaagcggct tgaacagatg ggggcggagc tcaccgagca gctgcaggcg 900
gtcgagcggc gcatttacga actcgccggc caagagttca acattaactc gccgaaacag 960
ctcgggacgg ttttatttga caagctgcag ctcccggtgt tgaaaaagac aaaaaccggc 1020
tattcgactt cagccgatgt gctagaaaag cttgcaccgc accatgaaat cgtcgaacat 1080
attttgcatt accgccaact cggcaagctg cagtcaacgt atattgaagg gctgctgaaa 1140
gtggtgcacc ccgtgacggg caaagtgcac acgatgttca atcaggcgtt gacgcaaacc 1200
gggcgcctca gctccgtcga accgaatttg caaaacattc cgattcggct tgaggaaggg 1260
cggaaaatcc gccaggcgtt cgtgccgtcg gagccggact ggctcatctt tgcggccgac 1320
tattcgcaaa tcgagctgcg cgtcctcgcc catatcgcgg aagatgacaa tttgattgaa 1380
gcgttccggc gctggttgga catccatacg aaaacagcca tggacatttt ccatgtgagc 1440
gaagaagacg tgacagccaa catgcgccgc caagcgaagg ccgtcaattt tggcatcgtg 1500
tacggcatta gtgattacgg tctggcgcaa aacttgaaca ttacgcgcaa agaagcggct 1560
gaatttattg agcgatattt tgccagtttt ccaggtgtaa agcaatatat ggacaacatt 1620
gtgcaagaag cgaaacaaaa agggtatgtg acgacgctgc tgcatcggcg ccgctatttg 1680
cccgatatta caagccgcaa cttcaacgtc cgcacgttcg ccgagcggac ggcgatgaac 1740
acaccgatcc agggatccgc tgccgacatc attaagaaag cgatgatcga tctaagcgtg 1800
agcgtgcgcg aagaacggct gcaggcgcgc ctgttgctgc aaggtcatga cgaactcatt 1860
ttggaggcgc cgaaagagga aatcggacgg ctgtgccgcc tcgttccgga agtgatggag 1920
caagccgtga cacttcgcgt gccgctgaaa gtcgattacc attacggtcc gacgtggtac 1980
gacgccaaat aa 1992

Claims (12)

1.单链DNA聚合酶Bst或这类DNA聚合酶的另一种聚合酶的融合聚合酶,所述单链DNA聚合酶Bst或这类DNA聚合酶的另一种聚合酶与NeqSSB蛋白或序列在不高于50%的程度上与NeqSSB相似的蛋白在所述聚合酶的N端使用示例性氨基酸序列Gly-Ser-Gly-Gly-Val-Asp的接头连接或在不使用接头的情况下直接融合,其中所述聚合酶以三种不同的变体存在。
2.根据权利要求1所述的融合DNA聚合酶NeqSSB-Bst,其特征在于,其包含Bst聚合酶的以下三种变体中的一种:
-由于点突变而使5'-3'活性丧失的DNA聚合酶|Bst的整个氨基酸序列;
-大片段-无5'-3'结构域的DNA聚合酶|Bst;
-短片段-两个外切核酸结构域都缺失的短版本。
3.根据权利要求1至2所述的融合DNA聚合酶NeqSSB-Bst,其特征在于,其与所有类型的DNA和RNA结合。
4.根据权利要求1至3所述的融合DNA聚合酶NeqSSB-Bst,其特征在于,其包含SEQ1所示的序列。
5.根据权利要求1至3所述的融合DNA聚合酶NeqSSB-Bst,其特征在于,其包含SEQ2所示的序列。
6.根据权利要求1至3所述的融合DNA聚合酶NeqSSB-Bst,其特征在于,其包含SEQ3所示的序列。
7.SEQ4中所示的编码所述融合DNA聚合酶NeqSSB-Bst全长的核酸分子。
8.SEQ5中所示的编码所述融合DNA聚合酶NeqSSB-Bst大片段的核酸分子。
9.SEQ6中所示的编码所述融合DNA聚合酶NeqSSB-Bst短片段的核酸分子。
10.根据权利要求7至9中任一项所述的编码所述融合DNA聚合酶NeqSSB-Bst的核酸分子。
11.在权利要求1中所限定的融合DNA聚合酶NeqSSB-Bst的制备方法,其特征在于:
-第一步包括在优化的条件下,在微生物振荡器中表达编码所述酶的基因:生长温度28℃至37℃,诱导后培养基的温育时间-3h至20h,诱导剂浓度-0.1mM至1mM IPTG,
-使用超声对所获得的细胞裂解物进行分解,并使用dsDNase消除DNA基因组污染,
-第二纯化步骤利用使用His-Trap珠的金属亲和色谱,
-下一步骤包括对制剂的三重透析(10mM Tris-HCl,pH 7.1,50mM KCl,1mM DTT,0.1mMEDTA,50%甘油,0.1%Triton X-100)、凝胶过滤和浓缩,
-所有过程均在4℃下进行,
-使用SDS-PAGE电泳测试所获得的蛋白的纯度,并使用EvaEZ荧光聚合酶活性测定试剂盒确定所获得的制剂的单位数量。
12.在第1至6段中所限定的融合单链DNA聚合酶在体外用于等温扩增反应的用途。
CN201980017798.1A 2018-06-27 2019-06-26 融合单链DNA聚合酶Bst、编码融合DNA聚合酶NeqSSB-Bst的核酸分子、其制备方法和用途 Pending CN111819188A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PLP.426093 2018-06-27
PL426093A PL426093A1 (pl) 2018-06-27 2018-06-27 Fuzyjna polimeraza kwasu jednołańcuchowego DNA Bst, cząsteczka kwasu nukleinowego kodująca fuzyjną polimerazę DNA NeqSSB-Bst, sposób jej otrzymywania oraz zastosowanie
PCT/PL2019/000046 WO2020005084A1 (en) 2018-06-27 2019-06-26 Fusion single-stranded dna polymerase bst, nucleic acid molecule encoding fusion dna polymerase neqssb-bst, method of preparation and utilisation thereof

Publications (1)

Publication Number Publication Date
CN111819188A true CN111819188A (zh) 2020-10-23

Family

ID=67402999

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980017798.1A Pending CN111819188A (zh) 2018-06-27 2019-06-26 融合单链DNA聚合酶Bst、编码融合DNA聚合酶NeqSSB-Bst的核酸分子、其制备方法和用途

Country Status (7)

Country Link
US (1) US20210254034A1 (zh)
EP (1) EP3814368A1 (zh)
JP (1) JP7579557B2 (zh)
CN (1) CN111819188A (zh)
IL (1) IL279262A (zh)
PL (1) PL426093A1 (zh)
WO (1) WO2020005084A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115094047A (zh) * 2022-06-24 2022-09-23 华南理工大学 一种直扩型Bst DNA聚合酶及其制备方法与应用

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009005289B4 (de) 2009-01-20 2023-06-22 Merck Patent Gmbh Materialien für organische Elektrolumineszenzvorrichtungen, Verfahren zu deren Herstellung und elektronische Vorrichtungen, enthaltend diese
PL241065B1 (pl) * 2020-06-26 2022-08-01 Geneme Spolka Z Ograniczona Odpowiedzialnoscia Zastosowanie fuzyjnej polimerazy DNA Bst-Nec do izotermalnego powielania specyficznych sekwencji wirusa SARS CoV-2
PL241698B1 (pl) * 2021-01-27 2022-11-21 Inst Biotechnologii I Medycyny Molekularnej Polimeraza Pwo-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy
CN112899255B (zh) * 2021-03-06 2022-02-25 苏州瀚源新酶生物科技有限公司 Dna聚合酶及其应用、重组载体及其制备方法和应用、重组工程菌及其应用
PL243940B1 (pl) * 2021-05-19 2023-11-06 Inst Biotechnologii I Medycyny Molekularnej Polimeraza Taq-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy
CN115058404A (zh) * 2022-07-25 2022-09-16 通用生物(南京)有限公司 一种新型的dna合成连接酶
CN115701839A (zh) * 2023-01-05 2023-02-14 深圳无微华斯生物科技有限公司 一种恒温扩增试剂盒及常温保存方法
CN119320460B (zh) * 2024-12-17 2025-03-14 中国农业科学院生物技术研究所 Bst DNA聚合酶和铁蛋白的融合蛋白及其突变体和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1934372B1 (en) * 2005-09-09 2013-02-20 Life Technologies Corporation Ssb - polymerase fusion proteins
US20160160193A1 (en) * 2014-08-27 2016-06-09 New England Biolabs, Inc. Fusion Polymerase and Method for Using the Same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG86311A1 (en) * 1997-04-10 2002-02-19 Univ Singapore Bacillus stearothermophilus dna polymerase i (klenow) clones with reduced 3'-to-5' exonuclease activity
WO2007050125A2 (en) * 2005-05-27 2007-05-03 William Marsh Rice University High processivity polymerases
US20130022980A1 (en) * 2009-02-04 2013-01-24 Lucigen Corporation Rna- and dna-copying enzymes
US20130260422A1 (en) 2011-09-01 2013-10-03 New England Biolabs, Inc. Compositions and Methods Relating to Variant DNA Polymerases and Synthetic DNA Polymerases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1934372B1 (en) * 2005-09-09 2013-02-20 Life Technologies Corporation Ssb - polymerase fusion proteins
US20160160193A1 (en) * 2014-08-27 2016-06-09 New England Biolabs, Inc. Fusion Polymerase and Method for Using the Same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MARCIN OLSZEWSKI ET AL.: "Fusion of Taq DNA polymerase with single-stranded DNA binding-like protein of Nanoarchaeum equitans-Expression and characterization", PLOS ONE, vol. 12, no. 9, pages 4 - 5 *
REBECCA B. KUCERA ET AL.: "DNA-Dependent DNA Polymerases", CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, pages 2 - 3 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115094047A (zh) * 2022-06-24 2022-09-23 华南理工大学 一种直扩型Bst DNA聚合酶及其制备方法与应用
CN115094047B (zh) * 2022-06-24 2023-06-20 华南理工大学 一种直扩型Bst DNA聚合酶及其制备方法与应用

Also Published As

Publication number Publication date
JP2021528968A (ja) 2021-10-28
EP3814368A1 (en) 2021-05-05
PL426093A1 (pl) 2020-01-02
JP7579557B2 (ja) 2024-11-08
US20210254034A1 (en) 2021-08-19
WO2020005084A1 (en) 2020-01-02
IL279262A (en) 2021-01-31

Similar Documents

Publication Publication Date Title
JP7579557B2 (ja) 融合一本鎖DNAポリメラーゼBst、融合DNAポリメラーゼNeqSSB-Bstをコードする核酸分子、その調製方法およびその利用
EP2352818B1 (en) Chimeric dna polymerases
JP4722035B2 (ja) Dnaポリメラーゼ融合物およびその使用
JP2000502882A (ja) サーモトガ由来のクローン化dnaポリメラーゼ類およびそれらの変異体
US20250257335A1 (en) Nucleic acid polymerase variants, kits and methods for template-independent rna synthesis
CA2415767A1 (en) High fidelity polymerases and uses thereof
JP2002253265A (ja) 改変された耐熱性dnaポリメラーゼ
US12065697B2 (en) B-family DNA polymerase variant and kit comprising the same
EP3645710A1 (en) Thermophilic dna polymerase mutants
HK40029655A (zh) 融合单链dna聚合酶bst、编码融合dna聚合酶neqssb-bst的核酸分子、其制备方法和用途
US20210324352A1 (en) Enhanced speed polymerases for sanger sequencing
JP3463780B2 (ja) 核酸増幅用dnaポリメラーゼ組成物
KR20030034183A (ko) 복합체 형성 방법
JP2003284576A (ja) 核酸増幅用dnaポリメラーゼ組成物
HK1216032B (zh) 嵌合dna聚合酶

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40029655

Country of ref document: HK

SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20201023

WD01 Invention patent application deemed withdrawn after publication